Nordex SE (LON:0MEC)
21.58
-0.02 (-0.09%)
At close: Aug 1, 2025
Intercept Pharmaceuticals Market Cap
Nordex SE has a market cap or net worth of 4.47 billion as of August 1, 2025. Its market cap has increased by 65.13% in one year.
Market Cap
4.47B
Enterprise Value
3.80B
Revenue
6.15B
Ranking
n/a
PE Ratio
86.42
Stock Price
$21.58
Market Cap Chart
Since May 22, 2001, Nordex SE's market cap has increased from 271.79M to 4.47B, an increase of 1,544.04%. That is a compound annual growth rate of 12.26%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Aug 1, 2025 | 4.47B | 102.23% |
Dec 30, 2024 | 2.21B | 3.54% |
Dec 29, 2023 | 2.13B | -14.01% |
Dec 30, 2022 | 2.48B | 32.89% |
Dec 30, 2021 | 1.87B | -20.55% |
Dec 30, 2020 | 2.35B | 113.57% |
Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
AstraZeneca | 175.60B |
HSBC Holdings | 160.06B |
Shell | 159.31B |
Unilever | 109.82B |
Rolls-Royce Holdings | 89.38B |
British American Tobacco p.l.c. | 88.30B |
Rio Tinto Group | 76.62B |
RELX PLC | 72.00B |